Safety and Angiographic Efficacy of Intra-Arterial Fibrinolytics as Adjunct to Mechanical Thrombectomy: Results from the INFINITY Registry
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background and Purpose: Data on safety and efficacy of intra-arterial (IA) fibrinolytics as adjunct to mechanical thrombectomy (MT) are sparse. Methods: INtra-arterial FIbriNolytics In ThrombectomY (INFINITY) is a retrospective multi-center observational registry of consecutive patients with anterior circulation large-vessel occlusion ischemic stroke treated with MT and adjunctive administration of IA fibrinolytics (alteplase [tissue plasminogen activator, tPA] or urokinase [UK]) at 10 European centers. Primary outcome was the occurrence of symptomatic intracranial hemorrhage (sICH) according to the European Cooperative Acute Stroke Study II definition. Secondary outcomes were mortality and modified Rankin Scale(mRS) scores at 3 months. Results: Of 5,612 patients screened, 311 (median age, 74 years; 44.1% female) received additional IA after or during MT (194 MT+IA tPA, 117 MT+IA UK). IA fibrinolytics were mostly administered for rescue of thrombolysis in cerebral infarction (TICI) 0-2b after MT (80.4%, 250/311). sICH occurred in 27 of 308 patients (8.8%), with an increased risk in patients with initial TICI0/1 (adjusted odds ratio[aOR], 2.3; 95% confidence interval [CI], 1.1 to 5.0 per TICI grade decrease) or in those with intracranial internal carotid artery occlusions (aOR, 3.7; 95% CI, 1.2 to 12.5). In patients with attempted rescue of TICI0-2b and available angiographic follow-up, 116 of 228 patients (50.9%) showed any angiographic reperfusion improvement after IA fibrinolytics, which was associated with mRS ≤2 (aOR, 3.1; 95% CI, 1.4 to 6.9). Conclusions: Administration of IA fibrinolytics as adjunct to MT is performed rarely, but can improve reperfusion, which is associated with better outcomes. Despite a selection bias, an increased risk of sICH seems possible, which underlines the importance of careful patient selection.
Abstract
Background and Purpose: Data on safety and efficacy of intra-arterial (IA) fibrinolytics as adjunct to mechanical thrombectomy (MT) are sparse. Methods: INtra-arterial FIbriNolytics In ThrombectomY (INFINITY) is a retrospective multi-center observational registry of consecutive patients with anterior circulation large-vessel occlusion ischemic stroke treated with MT and adjunctive administration of IA fibrinolytics (alteplase [tissue plasminogen activator, tPA] or urokinase [UK]) at 10 European centers. Primary outcome was the occurrence of symptomatic intracranial hemorrhage (sICH) according to the European Cooperative Acute Stroke Study II definition. Secondary outcomes were mortality and modified Rankin Scale(mRS) scores at 3 months. Results: Of 5,612 patients screened, 311 (median age, 74 years; 44.1% female) received additional IA after or during MT (194 MT+IA tPA, 117 MT+IA UK). IA fibrinolytics were mostly administered for rescue of thrombolysis in cerebral infarction (TICI) 0-2b after MT (80.4%, 250/311). sICH occurred in 27 of 308 patients (8.8%), with an increased risk in patients with initial TICI0/1 (adjusted odds ratio[aOR], 2.3; 95% confidence interval [CI], 1.1 to 5.0 per TICI grade decrease) or in those with intracranial internal carotid artery occlusions (aOR, 3.7; 95% CI, 1.2 to 12.5). In patients with attempted rescue of TICI0-2b and available angiographic follow-up, 116 of 228 patients (50.9%) showed any angiographic reperfusion improvement after IA fibrinolytics, which was associated with mRS ≤2 (aOR, 3.1; 95% CI, 1.4 to 6.9). Conclusions: Administration of IA fibrinolytics as adjunct to MT is performed rarely, but can improve reperfusion, which is associated with better outcomes. Despite a selection bias, an increased risk of sICH seems possible, which underlines the importance of careful patient selection.
참고문헌 (33)
- Rizvi A, "Redefining 'success' : a systematic review and meta-analysis comparing outcomes between incomplete and complete revascularization", J Neurointerv Surg, 11, pp.9~13 (2019)
- Liebeskind DS, "eTICI reperfusion : defining success in endovascular stroke therapy", J Neurointerv Surg, 11, pp.433~438 (2019)
- Kaesmacher J, "Systematic review and metaanalysis on outcome differences among patients with TICI2b versus TICI3 reperfusions : success revisited", J Neurol Neurosurg Psychiatry, 89, pp.910~917 (2018)
- Kaesmacher J, "Reasons for reperfusion failures in stentretriever-based thrombectomy : registry analysis and proposal of a classification system", AJNR Am J Neuroradiol, 39, pp.1848~1853 (2018)
- Leischner H, "Reasons for failed endovascular recanalization attempts in stroke patients", J Neurointerv Surg, 11, pp.439~442 (2019)
- Hill MD, "Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial", Lancet, 395, pp.878~887 (2020)
- Baek JH, "Stenting as a rescue treatment after failure of mechanical thrombectomy for anterior circulation large artery occlusion", Stroke, 47, pp.2360~2363 (2016)
- Meyer L, "Intracranial stenting after failed thrombectomy in patients with moderately severe stroke : a multicenter cohort study", Front Neurol, 11, pp.97~ (2020)
- Chang Y, "Rescue stenting for failed mechanical thrombectomy in acute ischemic stroke : a multicenter experience", Stroke, 49, pp.958~964 (2018)
- Grossberg JA, "Beyond large vessel occlusion strokes : distal occlusion thrombectomy", Stroke, 49, pp.1662~1668 (2018)
- Goyal M, "MeVO : the next frontier", J Neurointerv Surg, 12, pp.545~547 (2020)
- Kaesmacher J, "Improving mTICI2b reperfusion to mTICI2c", 3reperfusions: a retrospective observational study assessing technical feasibility, safety and clinical efficacy, 2018, pp.28, 274~282
- Yang M, "Low-dose rescue tirofiban in mechanical thrombectomy for acute cerebral large-artery occlusion", Eur J Neurol, 27, pp.1056~1061 (2020)
- Zaidi SF, "Intraarterial thrombolysis as rescue therapy for large vessel occlusions", Stroke, 50, pp.1003~1006 (2019)
- Anadani M, "Intra-arterial tissue plasminogen activator is a safe rescue therapy with mechanical thrombectomy", World Neurosurg, 123, pp.e604~e608 (2019)
- Kaesmacher J, "Safety and efficacy of intra-arterial urokinase after failed, unsuccessful, or incomplete mechanical thrombectomy in anterior circulation large-vessel occlusion stroke", JAMA Neurol, 77, pp.318~326 (2020)
- Powers WJ, "Guidelines for the early management of patients with acute ischemic stroke : 2019 update to the 2018 guidelines for the early management of acute ischemic stroke : a guideline for healthcare professionals from the American Heart Association", American Stroke Association, 2019, pp.50, e344~e418
- Kellert L, "Thrombolysis management in thrombectomy patients : real-life data from German stroke centres", Eur Stroke J, 2, pp.356~360 (2017)
- Heiferman DM, "Intra-arterial alteplase thrombolysis during mechanical thrombectomy for acute ischemic stroke", J Stroke Cerebrovasc Dis, 26, pp.3004~3008 (2017)
- Hacke W, "Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators", Lancet, 352, pp.1245~1251 (1998)
- Clopper CJ, "The use of confidence or fiducial limits illustrated in the case of the binomial", Biometrika, 26, pp.404~413 (1934)
- Goyal M, "Endovascular thrombectomy after largevessel ischaemic stroke : a meta-analysis of individual patient data from five randomised trials", Lancet, 387, pp.1723~1731 (2016)
- Castonguay AC, "Insights into intra-arterial thrombolysis in the modern era of mechanical thrombectomy", Front Neurol, 10, pp.1195~ (2019)
- Bracard S, "Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke(THRACE) : a randomised controlled trial", Lancet Neurol, 15, pp.1138~1147 (2016)
- Furlan A, "Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism", JAMA, 282, pp.2003~2011 (1999)
- Lee M, "Efficacy of intra-arterial fibrinolysis for acute ischemic stroke : meta-analysis of randomized controlled trials", Stroke, 41, pp.932~937 (2010)
- Cappellari M, "IER-SICH nomogram to predict symptomatic intracerebral hemorrhage after thrombectomy for stroke", Stroke, 50, pp.909~916 (2019)
- Lee YB, "Predictors and impact of hemorrhagic transformations after endovascular thrombectomy in patients with acute large vessel occlusions", J Neurointerv Surg, 11, pp.469~473 (2019)
- Kaesmacher J, "Hemorrhagic transformations after thrombectomy : risk factors and clinical relevance", Cerebrovasc Dis, 43, pp.294~304 (2017)
- Hassan AE, "A critical analysis of intra-arterial thrombolytic doses in acute ischemic stroke treatment", Neurocrit Care, 21, pp.119~123 (2014)
- Kadir RRA, "Urokinase plasminogen activator : a potential thrombolytic agent for ischaemic stroke", Cell Mol Neurobiol, 40, pp.347~355 (2020)
- Tan Q, "Urokinase, a promising candidate for fibrinolytic therapy for intracerebral hemorrhage", J Neurosurg, 126, pp.548~557 (2017)
- Arturo Renú, "The Chemical Optimization of Cerebral Embolectomy trial: Study protocol", International Journal of Stroke, 16(1), pp.110~116 (2021), SAGE Publications[DOI]